−320KRW
−4.88 BKRW
32.63 BKRW
10.78 M
About BIOTOXTECH
Sector
CEO
Jong-Gu Kang
Website
Headquarters
Cheongju-si
Employees (FY)
242
Founded
2000
ISIN
KR7086040003
FIGI
BBG000RW93Z5
Biotoxtech Co., Ltd. engages in the provision of non-clinical drug trials. It operates through the following business divisions: Safety Evaluation Research Field, Efficacy Evaluation Research Field, and Analysis Research Field. The Safety Evaluation Research Field division offers studies in areas including general toxicity, local toxicity, reproductive and developmental, genotoxicity, immunotoxicity, carcinogenicity, safety pharmacology, ecotoxicology, histopathology, and hematology. The Efficacy Evaluation Research Field division provides efficacy evaluation and screening materials of medical supplies, health supplements, and cosmetics. The Analysis Research Field division includes the analysis of pharmacokinetics and toxicokinetics, validation, and bioanalysis. The company was founded on August 23, 2000 and is headquartered in Cheongju-si, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 086040 is 5380 KRW — it has decreased by 2.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange BIOTOXTECH stocks are traded under the ticker 086040.
086040 stock is 6.94% volatile and has beta coefficient of 0.77. Check out the list of the most volatile stocks — is BIOTOXTECH there?
Yes, you can track BIOTOXTECH financials in yearly and quarterly reports right on TradingView.
086040 stock has fallen by 5.61% compared to the previous week, the month change is a 6.11% fall, over the last year BIOTOXTECH has showed a 47.97% decrease.
086040 net income for the last quarter is −94.05 M KRW, while the quarter before that showed −1.73 B KRW of net income which accounts for 94.55% change. Track more BIOTOXTECH financial stats to get the full picture.
Today BIOTOXTECH has the market capitalization of 87.44 B, it has decreased by 4.98% over the last week.
No, 086040 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 086040 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOTOXTECH stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 242.00 employees. See our rating of the largest employees — is BIOTOXTECH on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOTOXTECH technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOTOXTECH stock shows the sell signal. See more of BIOTOXTECH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOTOXTECH EBITDA is −4.54 B KRW, and current EBITDA margin is −15.46%. See more stats in BIOTOXTECH financial statements.